Healthcare provider profile · identity verified

Daniel A Trautman, MD

Pediatric Medicine · CEDAR RAPIDS, IA · NPI 1912985680

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1005	279
Levothyroxine Sodium	Levothyroxine Sodium	541	137
Losartan Potassium	Losartan Potassium	489	137
Pantoprazole Sodium	Pantoprazole Sodium	390	106
Metoprolol Succinate	Metoprolol Succinate	356	100
Omeprazole	Omeprazole	317	88
Amlodipine Besylate	Amlodipine Besylate	288	84
Lisinopril	Lisinopril	217	56
Ozempic	Semaglutide	216	40
Gabapentin	Gabapentin	211	66
Trazodone Hcl	Trazodone Hcl	210	58
Allopurinol	Allopurinol	201	56
Hydrochlorothiazide	Hydrochlorothiazide	197	65
Furosemide	Furosemide	180	56
Potassium Chloride	Potassium Chloride	180	55
Rosuvastatin Calcium	Rosuvastatin Calcium	172	49
Metformin Hcl	Metformin Hcl	162	50
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	151	44
Sertraline Hcl	Sertraline Hcl	143	34
Eliquis	Apixaban	122	30
Famotidine	Famotidine	117	34
Irbesartan	Irbesartan	115	30
Simvastatin	Simvastatin	115	31
Escitalopram Oxalate	Escitalopram Oxalate	107	35
Tamsulosin Hcl	Tamsulosin Hcl	105	35
Jardiance	Empagliflozin	100	21
Donepezil Hcl	Donepezil Hcl	95	20
Atenolol	Atenolol	94	26
Albuterol Sulfate Hfa	Albuterol Sulfate	92	35
Montelukast Sodium	Montelukast Sodium	86	22
Prednisone	Prednisone	85	61
Duloxetine Hcl	Duloxetine Hcl	84	27
Fluticasone Propionate	Fluticasone Propionate	81	29
Metformin Hcl Er	Metformin Hcl	81	26
Metoprolol Tartrate	Metoprolol Tartrate	79	19
Meloxicam	Meloxicam	78	40
Citalopram Hbr	Citalopram Hydrobromide	77	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	22
Tizanidine Hcl	Tizanidine Hcl	75	16
Clopidogrel	Clopidogrel Bisulfate	73	23
Memantine Hcl	Memantine Hcl	72	12
Azithromycin	Azithromycin	71	61
Spironolactone	Spironolactone	70	20
Ezetimibe	Ezetimibe	66	17
Farxiga	Dapagliflozin Propanediol	64	25
Bupropion Xl	Bupropion Hcl	61	22
Alendronate Sodium	Alendronate Sodium	58	18
Tramadol Hcl	Tramadol Hcl	58	22
Glimepiride	Glimepiride	57	17
Finasteride	Finasteride	56	16
Buspirone Hcl	Buspirone Hcl	52	14
Pregabalin	Pregabalin	50	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	11
Arnuity Ellipta	Fluticasone Furoate	43	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	12
Fenofibrate	Fenofibrate	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	12
Alprazolam	Alprazolam	35	16
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	19
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Xarelto	Rivaroxaban	34	suppressed
Midodrine Hcl	Midodrine Hcl	32	suppressed
Cephalexin	Cephalexin	31	27
Zolpidem Tartrate	Zolpidem Tartrate	29	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Klor-Con M20	Potassium Chloride	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Cefdinir	Cefdinir	21	19
Nifedipine Er	Nifedipine	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Amoxicillin	Amoxicillin	19	14
Baclofen	Baclofen	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Ramipril	Ramipril	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Nystatin	Nystatin	15	suppressed
Estradiol	Estradiol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Colchicine	Colchicine	13	suppressed
Fluvastatin Sodium	Fluvastatin Sodium	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Primidone	Primidone	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error